126 related articles for article (PubMed ID: 37802268)
1. Progression of Pediatric Crohn's Disease Is Associated With Anti-Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization.
Geem D; Hercules D; Pelia RS; Venkateswaran S; Griffiths A; Noe JD; Dotson JL; Snapper S; Rabizadeh S; Rosh JR; Baldassano RN; Markowitz JF; Walters TD; Ananthakrishnan A; Sharma G; Denson LA; Hyams JS; Kugathasan S
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):368-376.e4. PubMed ID: 37802268
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model.
Bossuyt P; Debeuckelaere C; Ferrante M; de Buck van Overstraeten A; Vanbeckevoort D; Billiet T; Wolthuis A; Cleynen I; Van Assche G; D'Hoore A; Vermeire S
J Crohns Colitis; 2018 Jan; 12(1):32-38. PubMed ID: 28981768
[TBL] [Abstract][Full Text] [Related]
4. Changes in Disease Behaviour and Location in Patients With Crohn's Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort.
Lo B; Vester-Andersen MK; Vind I; Prosberg M; Dubinsky M; Siegel CA; Bendtsen F; Burisch J
J Crohns Colitis; 2018 Feb; 12(3):265-272. PubMed ID: 29506105
[TBL] [Abstract][Full Text] [Related]
5. Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.
Magro F; Rodrigues-Pinto E; Coelho R; Andrade P; Santos-Antunes J; Lopes S; Camila-Dias C; Macedo G
Am J Gastroenterol; 2014 Jul; 109(7):1026-36. PubMed ID: 24796767
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Disease Behavior Evolution and Efficacy of Biologics in Reducing Progression in Pediatric Patients with Nonstricturing, Nonpenetrating Crohn's Disease at Diagnosis: A Single-Center Experience in Korea.
Kim HJ; Oh SH; Lee SH; Kim YB; Kim DY; Park SH; Ye BD; Yang SK; Kim KM
Gut Liver; 2021 Nov; 15(6):851-857. PubMed ID: 33833134
[TBL] [Abstract][Full Text] [Related]
7. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Kugathasan S; Denson LA; Walters TD; Kim MO; Marigorta UM; Schirmer M; Mondal K; Liu C; Griffiths A; Noe JD; Crandall WV; Snapper S; Rabizadeh S; Rosh JR; Shapiro JM; Guthery S; Mack DR; Kellermayer R; Kappelman MD; Steiner S; Moulton DE; Keljo D; Cohen S; Oliva-Hemker M; Heyman MB; Otley AR; Baker SS; Evans JS; Kirschner BS; Patel AS; Ziring D; Trapnell BC; Sylvester FA; Stephens MC; Baldassano RN; Markowitz JF; Cho J; Xavier RJ; Huttenhower C; Aronow BJ; Gibson G; Hyams JS; Dubinsky MC
Lancet; 2017 Apr; 389(10080):1710-1718. PubMed ID: 28259484
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
9. Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Plevris N; Fulforth J; Lyons M; Siakavellas SI; Jenkinson PW; Chuah CS; Lucaciu L; Pattenden RJ; Arnott ID; Jones GR; Lees CW
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1835-1844.e6. PubMed ID: 32798706
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.
Rodríguez-Lago I; Hoyo JD; Pérez-Girbés A; Garrido-Marín A; Casanova MJ; Chaparro M; Fernández-Clotet A; Castro-Poceiro J; García MJ; Sánchez S; Ferreiro-Iglesias R; Bastón I; Piqueras M; Careda LEIB; Mena R; Suárez C; Cordón JP; López-García A; Márquez L; Arroyo M; Alfambra E; Sierra M; Cano N; Delgado-Guillena P; Morales-Alvarado V; Aparicio JC; Guerra I; Aulló C; Merino O; Arranz L; Hidalgo MA; Llaó J; Plaza R; Molina G; Torres P; Pérez-Galindo P; Romero MG; Herrera-deGuise C; Armesto E; Mesonero F; Frago-Larramona S; Benítez JM; Calvo M; Martín MDCL; Elorza A; Larena A; Peña E; Rodríguez-Grau MDC; Miguel-Criado J; Botella B; Olmos JA; López L; Aguirre U; Gisbert JP;
United European Gastroenterol J; 2020 Nov; 8(9):1056-1066. PubMed ID: 32723069
[TBL] [Abstract][Full Text] [Related]
11. Antitubercular Therapy Given to Differentiate Crohn's Disease From Intestinal Tuberculosis Predisposes to Stricture Formation.
Gupta A; Pratap Mouli V; Mohta S; Kante B; Kalaivani M; Madhu D; Sahu P; Kumar S; Sharma R; Sahni P; Das P; Gupta SD; Makharia G; Kedia S; Ahuja V
J Crohns Colitis; 2020 Nov; 14(11):1611-1618. PubMed ID: 32369567
[TBL] [Abstract][Full Text] [Related]
12. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
Wu J; Lubman DM; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC; Griffiths AM; Baldassano RN; Noe JD; Rabizadeh S; Gulati AS; Rosh JR; Crandall WV; Higgins PDR; Stidham RW
Am J Gastroenterol; 2019 May; 114(5):777-785. PubMed ID: 31058681
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-up and Predictors of Complicated Disease Behavior in Pediatric Crohn's Disease Patients.
Kori M; Avidan M; Topf-Olivestone C
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):471-475. PubMed ID: 34984988
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
[TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.
Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Ekbom A; Rönnblom A
J Crohns Colitis; 2014 Mar; 8(3):215-22. PubMed ID: 24035547
[TBL] [Abstract][Full Text] [Related]
16. Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
Cernoch PS; Fournier N; Zeitz J; Scharl M; Morell B; Greuter T; Schreiner P; Misselwitz B; Safroneeva E; Schoepfer AM; Vavricka SR; Rogler G; Biedermann L;
Dig Dis Sci; 2020 Sep; 65(9):2654-2663. PubMed ID: 31797187
[TBL] [Abstract][Full Text] [Related]
17. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
19. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.
Lovasz BD; Lakatos L; Horvath A; Szita I; Pandur T; Mandel M; Vegh Z; Golovics PA; Mester G; Balogh M; Molnar C; Komaromi E; Kiss LS; Lakatos PL
World J Gastroenterol; 2013; 19(14):2217-26. PubMed ID: 23599648
[TBL] [Abstract][Full Text] [Related]
20. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
